1. Home
  2. MNPR vs HNST Comparison

MNPR vs HNST Comparison

Compare MNPR & HNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

N/A

Current Price

$70.28

Market Cap

587.4M

Sector

Health Care

ML Signal

N/A

Logo The Honest Company Inc.

HNST

The Honest Company Inc.

N/A

Current Price

$4.57

Market Cap

492.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
MNPR
HNST
Founded
2014
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
587.4M
492.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
MNPR
HNST
Price
$70.28
$4.57
Analyst Decision
Strong Buy
Buy
Analyst Count
12
7
Target Price
★ $130.17
$5.31
AVG Volume (30 Days)
127.0K
★ 2.5M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 54.99
N/A
EPS
N/A
★ 0.90
Revenue
N/A
★ $371,317,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.17
P/E Ratio
★ N/A
$4.97
Revenue Growth
★ N/A
N/A
52 Week Low
$50.07
$2.07
52 Week High
$124.82
$6.01

Technical Indicators

Market Signals
Indicator
MNPR
HNST
Relative Strength Index (RSI) 42.77 41.49
Support Level $66.88 $3.22
Resistance Level $75.33 $5.39
Average True Range (ATR) 4.74 0.31
MACD 0.73 0.00
Stochastic Oscillator 51.81 22.07

Price Performance

Historical Comparison
MNPR
HNST

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology. Its Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. The group radiopharmaceutical programs consist of Phase 1-stage MNPR-101-Zr for imaging cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac for the treatment of cancers that express urokinase plasminogen activator receptor (uPAR). It build drug development pipeline through both in-house efforts and licensing of late preclinical- and clinical-stage therapeutics. The Company operates as a single reportable segment, focusing on the development of clinical and preclinical product candidates.

About HNST The Honest Company Inc.

The Honest Co Inc is a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults. By combining thoughtful design with science-based innovation, the company delivers personal care products for everyone from babies to adults, spanning categories across wipes, personal care, diapers, and beauty. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.

Share on Social Networks: